Aqueous Phenol (use of 6%) in Unlicensed Indications in Pathological Muscle Hypertonia (611)


exp date isn't null, but text field is


A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.


Use the button below to access this resource item.

Access this resource


All Primary Care
Acute / All Inpatient

Last reviewed: 25 August 2021

Next review: 01 July 2023

Author(s): Alison Barclay

Version: 2

Author Email(s): [email protected]

Approved By: Regional Service Clinical Governance Group

Document Id: 611